Streamlining Bulk mAb Manufacturing: The projected growth in the biosimilars market will require increased bulk mAb manufacturing.
| Publicado en: | BioPharm International Vol. 35; no. 9; pp. 20 - 23 |
|---|---|
| Autor principal: | |
| Formato: | pictorial Journal Article |
| Publicado: |
MJH Life Sciences
Sep2022
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=158988574&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 158988574 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 1542166X 5NE jtl: BioPharm International issn: 1542166X maglogo: N pubinfo: dt: Sep2022 vid: 35 iid: 9 pid: 54670 pub: MJH Life Sciences place: Cranbury, New Jersey artinfo: ui: 158988574 158988574 158988574 158988574 ppf: 20 ppct: 3 formats: fmt: @attributes: type: P tig: atl: Streamlining Bulk mAb Manufacturing: The projected growth in the biosimilars market will require increased bulk mAb manufacturing. aug: au: MIRASOL, FELIZA sug: subj: Pharmaceutical Companies Manufacturing Industry Biosimilar Pharmaceuticals Supply and Distribution Antibodies, Monoclonal Supply and Distribution Organizational Compliance Health Services Needs and Demand Chronic Disease Drug Therapy Biosimilar Pharmaceuticals Therapeutic Use Antibodies, Monoclonal Therapeutic Use Antibodies, Monoclonal Administration and Dosage Biosimilar Pharmaceuticals Administration and Dosage Information Needs Healthcare Supply Chain Drug Stability Technology, Pharmaceutical Automation Quality Improvement pubtype: Trade Publication doctype: pictorial Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|